Institute of Human Virology

Institute of Human Virology Institute of Human Virology (IHV) is the first Institute at University of Maryland School of Medicine
(355)

The Institute of Human Virology (IHV) is the first center in the United States - perhaps the world - to combine the disciplines of basic science, epidemiology and clinical research in a concerted effort to speed the discovery of diagnostics and therapeutics for a wide variety of chronic and deadly viral and immune disorders - most notably HIV, the cause of AIDS. Formed in 1996 as a partnership between the State of Maryland, the City of Baltimore, the University System of Maryland and the University of Maryland Medical System, IHV is an institute of the University of Maryland School of Medicine and is home to some of the most globally-recognized and world-renowned experts in the field of human virology. The Institute, with its various laboratory and patient care facilities, is uniquely housed in a 100,000-square-foot building located in the center of Baltimore and our nation’s HIV/AIDS pandemic. IHV creates an environment where multidisciplinary research, education and clinical programs work closely together to expedite the scientific understanding of HIV/AIDS pathogenesis and to develop therapeutic interventions to make AIDS and virally-caused cancers manageable, if not curable, diseases. A particular focus of IHV includes learning how to utilize the body's natural chemistry for its own therapeutic potential and pursuing biologically-based treatment approaches that are less toxic to the body and, often, less costly to the patient and public. IHV also pursues the development of effective therapeutic and preventative vaccines, science's greatest hope in putting an end to the AIDS pandemic. IHV's more than 300 employees include 73 faculty whose research efforts are focused in the area of chronic human viral infection and disease. At present, more than 75 percent of the Institute's clinical and research effort is targeted at HIV infection, but also includes the Hepatitis C virus, herpes viruses and cancer research.

11/06/2025

From cultural preservation to health equity, Kerry Lessard shares how identity, tradition, and wellness intersect in urban spaces — and how Baltimore’s Indigenous voices continue to shape the city’s story.

Apple https://shorturl.at/Rd6RZ Spotify https://shorturl.at/kgPIe

👏 Congrats to Michael Wu, PhD candidate Institute of Human Virology for presenting his poster “A novel LNP/mRNA-based ST...
11/04/2025

👏 Congrats to Michael Wu, PhD candidate Institute of Human Virology for presenting his poster “A novel LNP/mRNA-based STING immunotherapy approach for chronic HBV infection” at the HBV 2025 Meeting in Berlin 🇩🇪 ! 🌍

“Each discovery brings us closer to transforming chronic HBV from a lifelong burden into a curable condition,” said Wu.

An estimated 537 million adults worldwide had diabetes, about 38 million in the U.S. 💙 Know your risk.💙 Get screened.💙 ...
11/03/2025

An estimated 537 million adults worldwide had diabetes, about 38 million in the U.S.
💙 Know your risk.
💙 Get screened.
💙 Support someone living with diabetes.

What do Edgar Allan Poe, mummies, and vampires have in common? Tuberculosis.This ancient disease has been found in Egypt...
10/31/2025

What do Edgar Allan Poe, mummies, and vampires have in common? Tuberculosis.

This ancient disease has been found in Egyptian mummies and even helped inspire the eerie, vampiric aesthetic that haunted much of Poe’s writing.

🎙️ In our podcast Halloween special, Dr. Paul Saleeb takes us through the history of TB to modern medicine. ▶️Link in comments▶️

The 2025 Institute of Human Virology Marlene and Stewart Greenebaum lecture on November 11, 2025, will feature speakers ...
10/31/2025

The 2025 Institute of Human Virology Marlene and Stewart Greenebaum lecture on November 11, 2025, will feature speakers Moupali Das, MD, MPH, and Anu Osinusi, MD, MPH of Gilead Sciences

10/27/2025

The University of Maryland School of Medicine received a $5.5 million endowment from the John C. Martin Foundation to the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM). This sizeable award inaugurates John C Martin Lectureship and Distinguished Chair , th...

🚨After Baltimore's mass overdose events, this episode revisits the opioid epidemic from two powerful voices: Candy from ...
10/25/2025

🚨After Baltimore's mass overdose events, this episode revisits the opioid epidemic from two powerful voices: Candy from the Baltimore Harm Reduction Coalition and Anthony, a resident and Narcotics Anonymous sponsor with over 30 years clean.

Spotify- https://open.spotify.com/show/5y7MDdZkL7hieUcabs0EuS
Apple- https://podcasts.apple.com/us/podcast/going-viral-from-baltimore-to-the-world-an-ihv-podcast/id1827982420
YouTube-
https://music.youtube.com/playlist?list=PLP5e-ILuYH-OKH_ipQz8AG_z-4wpjOSIW

🩷🎗️🩷 When breast cancer is found early, the survival rate is 99%! Dr. Omer Awan of Diagnostic Radiology and Nuclear Medi...
10/13/2025

🩷🎗️🩷 When breast cancer is found early, the survival rate is 99%! Dr. Omer Awan of Diagnostic Radiology and Nuclear Medicine at the University of Maryland School of Medicine explains why mammograms are essential. Early detection saves lives 🩷🎗️🩷

In light of October being Breast Cancer Awareness Month, a doctor describes compelling reasons for women to get screened for breast cancer with mammograms.

🆕 Marie-Claude Lavoie of Ciheb Global guest edited a new JIAS supplement on person-centered HIV prevention. The Suppleme...
10/08/2025

🆕 Marie-Claude Lavoie of Ciheb Global guest edited a new JIAS supplement on person-centered HIV prevention. The Supplement is now available open access: https://bit.ly/JIASPCC 👏🏽👏🏽👏🏽

Click on the title to browse this issue

✨A new research framework offers pathways to improve re-engagement and ensure people living with HIV can thrive with con...
09/25/2025

✨A new research framework offers pathways to improve re-engagement and ensure people living with HIV can thrive with continuous care, published in The Lancet HIV with Ciheb Global Dr. Marie-Claude Lavoie.

📖 Read more: https://www.sciencedirect.com/science/article/pii/S2352301825001900?dgcid=author

🌍 40–50% of people diagnosed with HIV experience disengagement from care.
Breaking the cycle of treatment interruption is critical for both individual health and epidemic control.

A new framework by Dr. Marie-Claude Lavoie and Dr. Elvin H Geng of the Division of Infectious Diseases, Washington University in St. Louis School of Medicine, highlights how research and interventions can be strengthened to support continuous HIV care and re-engagement.

🔗 https://www.sciencedirect.com/science/article/pii/S2352301825001900?dgcid=author

Address

725 W Lombard Street
Baltimore, MD
21201

Opening Hours

Monday 8:30am - 5pm
Tuesday 8:30am - 5pm
Wednesday 8:30am - 5pm
Thursday 8:30am - 5pm
Friday 8:30am - 5pm

Website

Alerts

Be the first to know and let us send you an email when Institute of Human Virology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

The Institute of Human Virology (IHV) is the first center in the United States - perhaps the world - to combine the disciplines of basic science, epidemiology and clinical research in a concerted effort to speed the discovery of diagnostics and therapeutics for a wide variety of chronic and deadly viral and immune disorders - most notably HIV, the cause of AIDS.

Formed in 1996 as a partnership between the State of Maryland, the City of Baltimore, the University System of Maryland and the University of Maryland Medical System, IHV is an institute of the University of Maryland School of Medicine and is home to some of the most globally-recognized and world-renowned experts in the field of human virology. IHV was co-founded by Robert Gallo, MD, director of the of the IHV, William Blattner, MD, retired since 2016 and formerly associate director of the IHV and director of IHV’s Division of Epidemiology and Prevention and Robert Redfield, MD, resigned in March 2018 to become director of the U.S. Centers for Disease Control and Prevention (CDC) and formerly associate director of the IHV and director of IHV’s Division of Clinical Care and Research. In addition to the two Divisions mentioned, IHV is also comprised of a Basic Science Division, Vaccine Research Division, Immunotherapy Division, Center for International Health, Education and Biosecurity (CIHEB) and four Scientific Core Facilities.

The Institute, with its various laboratory and patient care facilities, is uniquely housed in a 250,000-square-foot building located in the center of Baltimore and our nation’s HIV/AIDS pandemic. IHV creates an environment where multidisciplinary research, education, and clinical programs work closely together to expedite the scientific understanding of HIV/AIDS pathogenesis and to develop therapeutic interventions to make AIDS and virally-caused cancers manageable, if not curable, diseases.

A particular focus of IHV includes learning how to utilize the body's natural chemistry for its own therapeutic potential and pursuing biologically-based treatment approaches that are less toxic to the body and, often, less costly to the patient and public. IHV also pursues the development of effective therapeutic and preventative vaccines, science's greatest hope in putting an end to the AIDS pandemic.L